Following on from our launch day review of AMD's reference rx 7800 xt graphics card, today we turn our attention to the ...

Faricimab showed better control of PED, SHRM, and HRF compared to aflibercept in treatment-naïve nAMD and PCV patients. Both faricimab and aflibercept improved BCVA and reduced CMT, but faricimab ...

University of Minnesota Medical School researchers have shown that reducing chronic inflammation can significantly protect against age-related macular degeneration (AMD)-like pathology in preclinical ...

Advanced Micro Devices, Inc. is upgraded to 'Hold' as AI momentum and strong Q3 results are offset by an already generous valuation. Q3 saw an impressive 36% revenue growth and robust Data Center ...

AMD's Ryzen CPUs currently dominate the market for gaming—seriously, all our current recommendations, whatever your budget, are AMD chips. And we've long suspected the company's next generation of ...

Please provide your email address to receive an email when new articles are posted on . In AVONELLE-X, PULSAR and Portal, patients maintained visual acuity and central subfield thickness. No safety ...

One of the big features that AMD fans boast about when extolling the virtues of the Ryzen platform is forward compatibility. This very writer bought an ASRock X570 Taichi motherboard way back in 2019 ...

A new leak suggests AMD’s upcoming flagship could pack 12,288 cores, potentially rivaling or even surpassing NVIDIA’s RTX 5090 in raw performance. A new leak has popped up for the AMD RX 10950 XTX GPU ...

CNET’s expert staff reviews and rates dozens of new products and services each month, building on more than a quarter century of expertise. At CNET, we've been looking for high-tech ways to cool off, ...

A tabletop device that delivers various wavelengths of light therapy to the back of the eye to activate cellular function in people with intermediate dry age-related macular degeneration (AMD) ...

AMD's next-generation Threadripper CPUs are coming and coming soon, but official announcements are thin on the ground. With a little digging, though, VideoCardz has figured out some of the pricing for ...

Alcon has inked a deal to acquire LumiThera and its light-based therapy for dry age-related macular degeneration, which obtained a groundbreaking FDA clearance late last year. The Valeda system ...